Skip to main content
Top
Published in: Neurological Sciences 2/2013

Open Access 01-02-2013 | Original Article

Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis

Authors: Emily J. Hadgkiss, George A. Jelinek, Tracey J. Weiland, Greg Rumbold, Claire A. Mackinlay, Siegfried Gutbrod, Ian Gawler

Published in: Neurological Sciences | Issue 2/2013

Login to get access

Abstract

There is a strong body of evidence that supports the use of non-drug therapies in the management of people with multiple sclerosis (MS). A 5-day residential retreat for people with MS in Victoria, Australia, promotes lifestyle modification within a patient-centred model of care. Analysis of the health-related quality of life (HRQOL) of the retreat participants was undertaken using the MSQOL-54, prior to attendance, 1 and 5 years after the retreat. 274 retreat participants (71%) completed baseline questionnaires. Despite the usually progressive nature of MS, the cohort demonstrated clinically and statistically significant improvements in HRQOL. One year after attending the retreat, median improvements of 11.3% were observed in the overall quality of life domain (p < 0.001); 18.6% in the physical health composite (p < 0.001); and 11.8% in the mental health composite (p < 0.001). In the subset of 165 who had reached the 5-year time-point, there was a 19.5% median improvement in overall quality of life (p < 0.001); 17.8% in the physical health composite (p < 0.001) and 22.8% in the mental health composite (p < 0.001), compared to baseline. Attendance at a retreat promoting lifestyle modification for the integrated management of MS appears to have positive effects on short and medium-term HRQOL. Non-drug therapies should be considered as part of any comprehensive treatment plan for people with MS.
Literature
2.
go back to reference Koutsouraki E, Costa V, Baloyannis S (2010) Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 22:2–13PubMedCrossRef Koutsouraki E, Costa V, Baloyannis S (2010) Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 22:2–13PubMedCrossRef
3.
go back to reference Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3:709–718PubMedCrossRef Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3:709–718PubMedCrossRef
4.
go back to reference Ziemssen T (2009) Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 277(Suppl 1):S37–S41PubMedCrossRef Ziemssen T (2009) Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 277(Suppl 1):S37–S41PubMedCrossRef
6.
go back to reference Clegg A, Bryant J (2001) Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. Expert Opinion on Pharmacother 2:623–639CrossRef Clegg A, Bryant J (2001) Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. Expert Opinion on Pharmacother 2:623–639CrossRef
7.
go back to reference Chaudhuri A, Behan PO (2005) Treatment of multiple sclerosis: beyond the NICE guidelines. QJM 98:373–378PubMedCrossRef Chaudhuri A, Behan PO (2005) Treatment of multiple sclerosis: beyond the NICE guidelines. QJM 98:373–378PubMedCrossRef
8.
go back to reference Bryant J, Clegg A, Milne R (2001) Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost? J Neurol Neurosurg Psychiatry 70:574–579PubMedCrossRef Bryant J, Clegg A, Milne R (2001) Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost? J Neurol Neurosurg Psychiatry 70:574–579PubMedCrossRef
9.
go back to reference Tremlett H, Zhao Y, Ricckmann P, Hutchinson M (2010) New perspectives in the natural history of multiple sclerosis. Neurol 74:2004–2015CrossRef Tremlett H, Zhao Y, Ricckmann P, Hutchinson M (2010) New perspectives in the natural history of multiple sclerosis. Neurol 74:2004–2015CrossRef
10.
go back to reference D’Hooghe MB, Nagels G, Bissay V, De Keyser J (2010) Modifiable factors influencing relapses and disability in multiple sclerosis. Mult Scler 16:773–785PubMedCrossRef D’Hooghe MB, Nagels G, Bissay V, De Keyser J (2010) Modifiable factors influencing relapses and disability in multiple sclerosis. Mult Scler 16:773–785PubMedCrossRef
11.
go back to reference Jelinek GA, Hassed CS (2009) Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care 17:55–61PubMed Jelinek GA, Hassed CS (2009) Managing multiple sclerosis in primary care: are we forgetting something? Qual Prim Care 17:55–61PubMed
12.
go back to reference Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA (2009) Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complem Ther Med 17:216–223CrossRef Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA (2009) Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complem Ther Med 17:216–223CrossRef
13.
go back to reference Stuifbergen AK, Morris M, Jung JH, Pierini D, Morgan S (2010) Benefits of wellness interventions for persons with chronic and disabling conditions: a review of the evidence. Disabil Health J 3:133–145PubMedCrossRef Stuifbergen AK, Morris M, Jung JH, Pierini D, Morgan S (2010) Benefits of wellness interventions for persons with chronic and disabling conditions: a review of the evidence. Disabil Health J 3:133–145PubMedCrossRef
14.
go back to reference Watt D, Verma S, Flynn L (1998) Wellness programs: a review of the evidence. CMAJ 158:224–230PubMed Watt D, Verma S, Flynn L (1998) Wellness programs: a review of the evidence. CMAJ 158:224–230PubMed
15.
go back to reference Li MP, Jelinek GA, Weiland TJ, Mackinlay CA, Dye S, Gawler I (2010) Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Qual Prim Care 18:379–389PubMed Li MP, Jelinek GA, Weiland TJ, Mackinlay CA, Dye S, Gawler I (2010) Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Qual Prim Care 18:379–389PubMed
17.
go back to reference Jelinek GA (2005) Taking control of multiple sclerosis: natural and medical therapies to prevent its progression. Fleetbooks, Lancaster Jelinek GA (2005) Taking control of multiple sclerosis: natural and medical therapies to prevent its progression. Fleetbooks, Lancaster
18.
go back to reference Jelinek GA (2010) Overcoming multiple sclerosis: an evidence-based guide to recovery. Allen and Unwin, Sydney Jelinek GA (2010) Overcoming multiple sclerosis: an evidence-based guide to recovery. Allen and Unwin, Sydney
20.
go back to reference Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4:187–206PubMedCrossRef Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW (1995) A health-related quality of life measure for multiple sclerosis. Qual Life Res 4:187–206PubMedCrossRef
21.
go back to reference Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z (2006) Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 240:77–80PubMedCrossRef Idiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z (2006) Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci 240:77–80PubMedCrossRef
22.
go back to reference Heiskanen S, Merilainen P, Pietila A-M (2007) Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients. Scandinav J Caring Sci 21:199–206CrossRef Heiskanen S, Merilainen P, Pietila A-M (2007) Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients. Scandinav J Caring Sci 21:199–206CrossRef
23.
go back to reference Pekmezovic T, Kisic Tepavcevic D, Kostic J, Drulovic J (2007) Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res 16:1383–1387PubMedCrossRef Pekmezovic T, Kisic Tepavcevic D, Kostic J, Drulovic J (2007) Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res 16:1383–1387PubMedCrossRef
24.
go back to reference Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P (1999) Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 67:158–162PubMedCrossRef Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P (1999) Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 67:158–162PubMedCrossRef
25.
go back to reference Miller D, Rudick RA, Hutchinson M (2010) Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life. Neurol 74(Suppl 3):S24–S35 Miller D, Rudick RA, Hutchinson M (2010) Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life. Neurol 74(Suppl 3):S24–S35
26.
go back to reference Nortvedt MW, Riise T (2003) The use of quality of life measures in multiple sclerosis research. Mult Scler 9:63–72PubMedCrossRef Nortvedt MW, Riise T (2003) The use of quality of life measures in multiple sclerosis research. Mult Scler 9:63–72PubMedCrossRef
27.
go back to reference Opara JA, Jaracz K, Brola W (2010) Quality of life in multiple sclerosis. J Med Life 3:352–358PubMed Opara JA, Jaracz K, Brola W (2010) Quality of life in multiple sclerosis. J Med Life 3:352–358PubMed
28.
go back to reference Gold SM, Schulz H, Monch A, Schulz KH, Heesen C (2003) Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 9:404–410PubMedCrossRef Gold SM, Schulz H, Monch A, Schulz KH, Heesen C (2003) Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 9:404–410PubMedCrossRef
29.
go back to reference Ingram G, Colley E, Ben-Shlomo Y, Cossburn M, Hirst C, Pickersgill T, Robertson N (2010) Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 16:472–479PubMedCrossRef Ingram G, Colley E, Ben-Shlomo Y, Cossburn M, Hirst C, Pickersgill T, Robertson N (2010) Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 16:472–479PubMedCrossRef
30.
31.
go back to reference Dennison L, Moss-Morris R, Chalder T (2009) A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 29:141–153PubMedCrossRef Dennison L, Moss-Morris R, Chalder T (2009) A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 29:141–153PubMedCrossRef
32.
go back to reference White CP, White MB, Russell CS (2008) Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress? J Neurosci Nurs 40:85–95PubMedCrossRef White CP, White MB, Russell CS (2008) Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress? J Neurosci Nurs 40:85–95PubMedCrossRef
33.
go back to reference Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731PubMedCrossRef Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731PubMedCrossRef
34.
go back to reference Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M (2002) Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 64:803–809PubMedCrossRef Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M (2002) Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 64:803–809PubMedCrossRef
35.
go back to reference Flynn S (2002) Multiple sclerosis: the Treetops model of residential care. Br J Nurs 11(9):635–642PubMed Flynn S (2002) Multiple sclerosis: the Treetops model of residential care. Br J Nurs 11(9):635–642PubMed
36.
go back to reference Rothwell PM, McDowell Z, Wong CK, Dorman PJ (1997) Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580–1583PubMedCrossRef Rothwell PM, McDowell Z, Wong CK, Dorman PJ (1997) Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580–1583PubMedCrossRef
37.
go back to reference Pelzang R (2010) Time to learn: understanding patient-centred care. Br J Nurs 19:912–917PubMed Pelzang R (2010) Time to learn: understanding patient-centred care. Br J Nurs 19:912–917PubMed
38.
go back to reference Wallin MT (2010) Integrated multiple sclerosis care: new approaches and paradigm shifts. J Rehab Res Dev 47:ix–xiv Wallin MT (2010) Integrated multiple sclerosis care: new approaches and paradigm shifts. J Rehab Res Dev 47:ix–xiv
39.
go back to reference Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J (2007) Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage 30:21–29PubMed Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J (2007) Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage 30:21–29PubMed
40.
go back to reference Kessler TM, Fowler CJ, Panicker JN (2009) Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 9:341–350PubMedCrossRef Kessler TM, Fowler CJ, Panicker JN (2009) Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 9:341–350PubMedCrossRef
41.
go back to reference Tepavcevic DK, Kostic J, Basuroski ID, Stojsavljevic N, Pekmezovic T, Drulovic J (2008) The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 14:1131–1136PubMedCrossRef Tepavcevic DK, Kostic J, Basuroski ID, Stojsavljevic N, Pekmezovic T, Drulovic J (2008) The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 14:1131–1136PubMedCrossRef
42.
go back to reference Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM (2009) Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 6:96–107PubMedCrossRef Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM (2009) Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 6:96–107PubMedCrossRef
43.
go back to reference Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N (2003) Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 9:1–5PubMedCrossRef Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N (2003) Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 9:1–5PubMedCrossRef
44.
go back to reference Hopman WM, Coo H, Pavlov A, Day AG, Edgar CM, McBride EV, Brunet DG (2009) Multiple sclerosis: change in health-related quality of life over two years. Can J Neurol Sci 36:554–561PubMed Hopman WM, Coo H, Pavlov A, Day AG, Edgar CM, McBride EV, Brunet DG (2009) Multiple sclerosis: change in health-related quality of life over two years. Can J Neurol Sci 36:554–561PubMed
45.
go back to reference Solari A, Ferrari G, Radice D (2006) A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci 243:13–20PubMedCrossRef Solari A, Ferrari G, Radice D (2006) A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci 243:13–20PubMedCrossRef
46.
go back to reference Wynia K, Wijlen AV, Middel B, Reijneveld S, Meilof J (2011) Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP). Mult Scler. doi:10.1177/1352458511423935 PubMed Wynia K, Wijlen AV, Middel B, Reijneveld S, Meilof J (2011) Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP). Mult Scler. doi:10.​1177/​1352458511423935​ PubMed
47.
go back to reference Stuifbergen AK, Becker H, Blozis S, Timmerman G, Kullberg V (2003) A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch Phys Med Rehabil 84:467–476PubMedCrossRef Stuifbergen AK, Becker H, Blozis S, Timmerman G, Kullberg V (2003) A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch Phys Med Rehabil 84:467–476PubMedCrossRef
48.
Metadata
Title
Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis
Authors
Emily J. Hadgkiss
George A. Jelinek
Tracey J. Weiland
Greg Rumbold
Claire A. Mackinlay
Siegfried Gutbrod
Ian Gawler
Publication date
01-02-2013
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 2/2013
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-0982-4

Other articles of this Issue 2/2013

Neurological Sciences 2/2013 Go to the issue